Plus   Neg

Zimmer Biomet Names Vafa Jamali CEO Of New Spine And Dental Company - Quick Facts

Zimmer Biomet Holdings, Inc. (ZBH) announced the appointment of Vafa Jamali as CEO of NewCo, the publicly traded company that will be created by a spin off transaction. Jamali most recently served as the Chief Commercial Officer of Rockley Photonics.

Previously, Vafa Jamali was Senior Vice President and President of Respiratory, Gastrointestinal & Informatics (RGI) at Medtronic. Prior to Medtronic, he held leadership roles at Covidien, Cardinal Health, and Baxter. Jamali also serves on the Board of Directors for Baylis Medical.

NewCo will be comprised of the company's current Spine and Dental businesses.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Johnson & Johnson's (JNJ) Covid-19 vaccine is expected to be back on track as early as this weekend as a decision is expected after the advisory panel meeting of the U.S. Centers for Disease Control and Prevention (CDC) slated on April 23, according to Dr. Anthony Fauci, the chief medical adviser to President Joe Biden. MK-4482, the experimental antiviral drug for COVID-19, showed promise to prevent and treat SARS-CoV-2 infection in hamster study, according to the scientists of National Institutes of Health or NIH. The drug significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection. MK-4482, delivered orally, is now in Phase 2 and 3 human clinical studies. Beverages giant Coca-Cola reported a 19 percent decline in profit for the second quarter from last year as a revenue growth of 5 percent and improved margins were offset by higher income taxes and interest expense. However, adjusted earnings per share and revenues topped analysts' expectations. The company also maintained its adjusted earnings and organic revenue growth outlook for fiscal 2021.
Follow RTT